B2B Matchmaking Session Between Afghan and Indian Investors | 29 October, 2015

As per the companies midterm strategy plan "Reva Pharma" has taken Afghanistan as the next emerging market in its vision module. The company participated at the 1st HEALTH Pharma EXPO 2015 at Kabul from 28th to 30th October. The participation was organized by Afghanistan Expo Centre along with support of Health Ministry and India Embassy. The members attending the Summit & Exhibition were: Pawan Kashyap and Gurpreet Sandhu. Moreover, Dr Sandhu being Honorary advisor to Pharmexcil also interacted with officers of Ministry of Health Afghanistan and Trade Associations related to Health care & pharmaceuticals.

On the Second day of the "Afghanistan Health Expo", Afghanistan Expo Center and Afghanistan Investment Support Agency (AISA) organized a B2B Matchmaking session to bring together potential Afghan and Indian investors and businessmen in the health sector. The aim of the session was to provide a platform for the Afghan investors to meet their Indian counterparts and discuss potential areas of joint investments in hospitals, medicine and medical equipment manufacturing, diagnostic centers, and laboratories.

Initially, Mr. Sandhu- Senior Advisor at the Ministry of Commerce of the Republic of India- conducted a presentation highlighting the potentials of business ties between Afghan and Indian business community functioning in the Health sector. He emphasized that the government of India is committed to export highest quality medicine to Afghanistan in the short and medium term and for the long term sustainability of the health industry in Afghanistan, they will encourage the Indian investors to invest in the health sector of the country.

Following Mr. Sandhu, Mr. Ahmad Waleed Majidyar- Deputy Director for Investment Promotion of AISA- conducted a presentation highlighting the achievements of the Health sector during the last decade, potential investment opportunities, and incentives offered by the government of Afghanistan to private domestic and foreign investors. Mr. Majidyar said that more than 300 million USD goes out of Afghanistan for medical treatments and more than 800 million USD worth of medicines are imported to the country on annual basis. Thus, he urged the Indian investors to invest in the healthcare industry of Afghanistan through joint partnerships with the domestic firms, establish PPP with the government or invest as the sole- proprietors. He also emphasized that Afghanistan could be a hub for Indian investors to manufacture medicines and medical equipment and further export them to the Central Asian countries.

At the end of the session, the Afghan and Indian investors were given the opportunity to discuss mutual areas of partnership on One to One basis. Both Afghan and Indian companies discussed a large number of business deals which could be tied between them in near future.